How Seed Oil Linoleic Acid May Drive the Modern Cancer Epidemic

Why this matters: Cancer incidence has risen from a lifetime risk of approximately 5% in 1900 to 30-50% today. While aging and improved detection explain part of this trend, dietary shifts—specifically the explosion of industrial seed oil consumption—may represent an underappreciated environmental driver that reshapes human biochemistry at the cellular level.

What was studied: This narrative review synthesizes epidemiological, clinical trial, and preclinical data to evaluate whether excess dietary linoleic acid (LA), the dominant omega-6 fatty acid in seed oils, creates a biochemical 'pro-cancer terrain.' It also assesses therapeutic strategies, including ketogenic diets and a proposed 'terrain restoration' protocol. The author traces LA intake from roughly 1-2% of calories in pre-industrial populations to over 7% in modern Western diets, noting a parallel 136% rise in adipose tissue LA content (from ~8% in 1960 to ~18% by 2008).

Key results: The review identifies four major mechanistic pathways through which excess LA may promote carcinogenesis: (1) Oxidative stress and lipid peroxidation—LA's chemical vulnerability produces reactive aldehydes like 4-hydroxynonenal (4-HNE) that damage DNA, proteins, and membranes; (2) Mitochondrial dysfunction—LA metabolites may drive succinate-mediated pseudohypoxia and impair mitophagy; (3) Chronic inflammation—LA is a precursor to arachidonic acid, which COX-2 converts to pro-inflammatory prostaglandin E2 (PGE2), a known tumor promoter; (4) Gut dysbiosis—high LA intake may compromise intestinal barrier integrity and alter microbiota composition, impairing immune surveillance. Historical RCT data are cited as supporting evidence: the Los Angeles Veterans Administration Trial found 25% higher cancer incidence in high-LA groups, and re-analysis of the Sydney Diet Heart Study showed increased all-cause mortality (HR 1.62) when saturated fats were replaced with safflower oil.

Implications: The review challenges blanket ketogenic diet recommendations for cancer patients, arguing that severe carbohydrate restriction can worsen LA-induced dysbiosis by starving beneficial gut bacteria of fermentable fiber, reducing short-chain fatty acid production. Instead, it outlines a phased 'terrain restoration' strategy: first, reduce dietary LA by eliminating seed oils; second, gradually reintroduce selective prebiotic fibers; third, supplement with pentadecanoic acid (C15:0), an odd-chain saturated fatty acid proposed to support mitochondrial function and mitophagy.

Caveats: Large prospective cohorts and a 2025 meta-analysis of 4.1 million participants across 150 cohorts found no significant excess cancer risk across LA intake quintiles. The author acknowledges that most human cohorts sample populations already consuming high LA (5-8% of calories), leaving insufficient exposure contrast to detect threshold effects. Most mechanistic evidence is preclinical, often using supraphysiological doses, and the proposed terrain restoration protocol lacks clinical validation. Confounding by smoking, environmental toxins, and diagnostic improvements complicates historical correlations.